Skip to main content
Log in

Expression of fas ligand in human colon cancer cell lines

  • Basic Investigation
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective: To investigate the expression of Fas ligand in human colon carcinoma cell lines. Methods: A total of six human colon cancer cell lines were examined for the expression of Fas ligand mRNA and cell surface protein by using RT-PCR and flow cytometry respectively. Results: The results showed that Fas ligand mRNA was expressed in all of the six cancer cell lines and Fas ligand cell surface protein was expressed in part of them. Conclusion: These data suggest that Fas ligand was expressed, at least in part, in human colon cancer cell lines and might facilitate to escape from immune surveillance of the host.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nagata S, Golstein P. The Fas death factor[J]. Science 1995; 267: 1449.

    Article  PubMed  CAS  Google Scholar 

  2. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege[J]. Science 1995; 270: 1189.

    Article  PubMed  CAS  Google Scholar 

  3. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection[J]. Nature 1995; 377: 630.

    Article  PubMed  CAS  Google Scholar 

  4. Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape[J]. Science 1996; 274: 1363.

    Article  PubMed  CAS  Google Scholar 

  5. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis[J]. Science 1997; 275: 960.

    PubMed  CAS  Google Scholar 

  6. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual(M). 2nd. Woodbury, New york: Cold Spring Harbor Laboratory Press 1989; 672.

    Google Scholar 

  7. O’Connell J, O’Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand[J]. J Exp Med 1996; 184: 1075.

    Article  PubMed  CAS  Google Scholar 

  8. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells—a mechanism of immune evasion[J]? Natl Med 1996; 2: 1361.

    Article  CAS  Google Scholar 

  9. Saas P, Walker PR, Hahne M, et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain[J]? J Clin Invest 1997; 99: 1173.

    Article  PubMed  CAS  Google Scholar 

  10. Shiraki K, Tsuji N, Shioda T, et al. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas[J]. Proc Natl Acad Sci USA 1997; 94: 6420.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ding Er-xun.

Additional information

Foundation item: This work was supported by the National Natural Science Foundation of China (No. 39900143)

Biography: ZHANG Jian-jun(1971–), associate professor, Department of General Surgery, No. 150 Hospital of PLA, majors in oncology and surgery. Now works at Department of General Surgery, Changzheng Hospital, Second Military Medical University as a doctoral candidate.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Jj., Ding, Ex., Wang, Q. et al. Expression of fas ligand in human colon cancer cell lines. Chin. J. Cancer Res. 13, 262–264 (2001). https://doi.org/10.1007/s11670-001-0044-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-001-0044-6

Key words

CLC number

Navigation